泰凌医药复牌一度跌超16% 接获港府要求协助查实第三方合约

Core Viewpoint - TaiLing Pharmaceutical (01011) resumed trading today, experiencing a significant drop of over 16% at one point, and currently down 8.97% at HKD 0.71, with a trading volume of HKD 2.8566 million [1] Group 1 - The company was temporarily suspended from trading yesterday afternoon and resumed trading this morning [1] - On August 19, the company announced that it received a request from the Hong Kong government to assist in verifying a contract related to an independent third party [1] - The matter does not impact the company's daily operations, and as of the announcement date, the company's directors and senior management have no legal liabilities [1]